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Numerous natural products of clinical value are bio-
synthesized by polyketide synthases (PKSs) and
nonribosomal peptide synthetases (NRPSs), which
are multienzymes comprising modules of catalytic
domains. The key players in each module are carrier
proteins, which serve as attachment points for the
growing substrate chains. Thus, the details of carrier
protein-based substrate delivery to each active site
are central to understanding chain assembly in these
systems. In the enterobactin NRPS, communication
between a peptidyl carrier protein (PCP) and the
adjacent thioesterase (TE) domain occurs through
formation of a compact complex. Using NMR, we
show that the corresponding interaction between
a PKS acyl carrier protein (ACP) and its downstream
TE is fundamentally different: chain transfer occurs in
the absence of a protein-protein interface, with
contact limited to the substrate acyl terminus.
INTRODUCTION
The polyketides are a structurally diverse class of natural prod-
ucts, with applications in human and veterinary medicine.
Biosynthesis of these metabolites in bacteria is accomplished
by enzymatic machineries with highly divergent architectures.
Aromatic polyketides are typically generated by type II polyke-
tide synthases (PKSs), iteratively acting multienzyme complexes
comprising a small set of discrete proteins. In contrast, in the
construction of reduced polyketides, the biosynthetic tasks are
performed by protein domains housed within gigantic multien-
zymes (type I PKS) (Staunton and Weissman, 2001; Fischbach
and Walsh, 2006). In the modular class of type I PKS, the
domains are organized into functional units called ‘‘modules,’’
such that each module accomplishes a single round of chain
extension. The central component of each module is a small
(10 kDa), noncatalytic acyl carrier protein (ACP) domain, to
which the growing intermediates are tethered in covalent linkage
to a phosphopantetheine (Ppant) cofactor. Posttranslational
attachment of Ppant is carried out in trans by a dedicated phos-
phopantetheinyl transferase (PPTase) (Lambalot et al., 1996).
Analysis of a typical chain extension cycle reveals that the ACPChemistry & Biology 17,must communicate with all other domains within the module to
either receive or present substrate (Figure 1A). Faithful polyke-
tide assembly also requires that these ACP-based interactions
are regulated, so that the ACP cooperates with all catalytic part-
ners within its module, before transfer of the growing chain to the
subsequent module (Weissman and Mu¨ller, 2008).
The assembly line logic of PKS systems is also found in non-
ribosomal peptide synthetases (NRPSs), modular multienzymes
that condense a programmed series of amino acids into small
peptide metabolites. In NRPS systems, chain extension interme-
diates are tethered to peptidyl carrier protein (PCP) domains,
which share the core structural fold of ACP domains (Alekseyev
et al., 2007; Weber et al., 2000). Frueh et al. recently solved the
solution structure of an apo PCP (a PCP lacking its Ppant pros-
thetic group) from the enterobactin NRPS, attached to its natural
downstream partner, the chain-releasing thioesterase (TE)
(Frueh et al., 2008). The two domains form a tight complex, in
which the active sites are juxtaposed at a suitable distance for
substrate transfer. Similarly, the PCP has a specific binding
contact with the adjacent chain-extending condensation (C)
domain. Based on NMR studies of a PCP from the tyrocidine
(Tyc) NRPS, dynamic modulation of the structure is suggested
to guide selection of the appropriate partner domain within the
chain extension modules (Koglin et al., 2006). In its apo form,
the Tyc PCP domain occupies two stable conformations (called
the A and A/H states). Conversion to the holo form by addition of
Ppant, however, shifts the A-state equilibrium to the alternative
H-state equilibrium, comprising the A/H and H states. The A
state is preferentially recognized by the PPTase, and the H state
by an externally operating, proof-reading thioesterase (TEII)
domain (Yeh et al., 2004; Schwarzer et al., 2002). Although
such conformational selection has so far only been demon-
strated for these trans-acting enzymes, the data support amodel
in which conformational variability of the PCP is also used to
program alternative protein-protein interactions with potential
partners within the multienzymes.
Given the similarities between PKS and NRPS systems, it has
been suggested that partner choice in modular PKSs may also
be guided by conformational switching (Frueh et al., 2008;
Weissman and Mu¨ller, 2008; Kapur and Khosla, 2008; Lai
et al., 2006). High-resolution structural information is currently
available for only a single type I PKS ACP domain, ACP2 from
the erythromycin (DEBS) PKS, in its apo form (Alekseyev et al.,
2007). The domain was not reported to exhibit any conforma-
tional variation. Structures have also been determined by NMR
and X-ray crystallography for many ACP domains derived from705–716, July 30, 2010 ª2010 Elsevier Ltd All rights reserved 705
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Figure 1. ACP Analysis
(A) Consideration of a typical round of chain extension shows that the acyl-ACP domain must interact with all of the catalytic domains housed within the PKS
module: with the AT to receive the extender unit, with the KS to participate in the Claisen-like condensation, and with any reductive domains which are present.
Subsequently, it engages in chain transfer with a domain located in a downstream module, a KS or a TE.
(B) Multiple sequence alignment (ClustalW) of the ACPdomains from the DEBS system (ACPs 1–6), with those from the actinorhodin type II PKS (act ACP), and the
type II FAS ACPs of Bacillus subtilis and Escherichia coli. Residue numbering is according to the EryAIII protein (NCBI reference sequence YP_001102991.1).
Residues mentioned in the text are highlighted. The secondary structural elements as determined for ACP2 are shown (Alekseyev et al., 2007).
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Insights into Modular PKS Enzymologytype II PKS in their apo, holo, and acyl-modified forms (Evans
et al., 2008; Findlow et al., 2003; Li et al., 2003), as well as for
ACPs of the type II fatty acid synthases (FASs) (Kim et al.,
2006; Zornetzer et al., 2006; Xu et al., 2001; Roujeinikova et al.,
2002; Wong et al., 2002); despite sharing low overall sequence
homology with type I ACPs (as low as 4% identity) (Figure 1B),
all of the ACP domains exhibit a similar a-helical fold (Alekseyev
et al., 2007). Although both apo and holo type II ACPs (Kim et al.,
2006; Li et al., 2003; Findlow et al., 2003; Zornetzer et al., 2006)
show some conformational heterogeneity, many holo proteins
do not interact stably with their appended Ppant arms (Wong
et al., 2002; Xu et al., 2001; Kim et al., 2006; Li et al., 2003).
In these cases, the apo and holo forms of the domains are essen-
tially identical, and therefore the Ppant-induced conformational
modulation observed for NRPS PCPs does not appear to be
a conserved feature of PKS and FAS ACP domains. In addition,
recent work by us (Tran et al., 2008) and others (Chen et al., 2007)
has challenged the underlying assumption that ACP domains in
type I PKS systems must always form a protein-protein complex
in order to interact with partner domains. For example, PKS706 Chemistry & Biology 17, 705–716, July 30, 2010 ª2010 Elsevier Lketoreductase (KR) domains exhibit a high degree of tolerance
toward multiple ACP partners, suggesting that the KR domains
instead recognize ACP-tethered acyl chains (Chen et al., 2007).
Here, we report that another type I ACP, ACP6 from the DEBS
PKS, adopts a single conformation in solution in both its apo and
holo forms, as judged by solution phase NMR. Furthermore, as
we find no evidence that the domain interacts substantially
with its Ppant cofactor, we conclude that the apo and holo forms
are effectively equivalent. No contacts were observed to any of
several acyl chains when they were tethered in thioester linkage
to the ACP, further arguing against the conformational switching
model. Although transfer of the model substrate butyrate from
the ACP to the adjacent TE is highly efficient (Tran et al., 2008),
transacylation occurs in the absence of a defined protein-protein
interface between the ACP and TE domains; instead recognition
by the TE may be limited to the C1 carbonyl group of the
substrate acyl chain. Taken together, these data show that effec-
tive communication between acyl-ACP and TE occurs solely as
a result of the covalent tethering of the domains within a single
multienzyme (Tran et al., 2008). Thus, despite sharing a similartd All rights reserved
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Figure 2. Structure of ACP6
(A) NOE-based structure of ACP2 (PDB: 2JU1).
(B) CHESHIRE (chemical shift)-derived structure of ACP2.
(C) CHESHIRE-derived structure of ACP6. In each case, the active Ser is displayed in space-filling mode.
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key interdomain interactions within modular PKS and NRPS
systems.RESULTS
Structural Analysis of DEBS apo ACP6
Our initial aim was to collect structural data on ACP6 in order to
characterize any conformational variability induced by interac-
tion with Ppant or attached substrates. For these experiments,
discrete ACP6 was expressed as a C-terminal translational
fusion with glutathione-S-tranferase (GST), as described previ-
ously (Tran et al., 2008), and the GST tag was removed by
cleavage with PreScission Protease. In the final protein sample,
only the first five residues originate from the expression vector,
while residues 6–90 are identical to the DEBS residues 2809–
2893 (EryAIII, NCBI reference sequence YP_001102991.1). An
analogous construct was used to solve the structure of DEBS
ACP2 (46% sequence identity with ACP6) (Alekseyev et al.,
2007).
The [1H, 15N]-HSQC (heteronuclear single quantum coher-
ence) spectrum of ACP6 showed 76 of the 83 expected back-
bone amide signals (see Figure S1A available online). Each
residue contributed a single signal to the [1H, 15N]-HSQC spec-
trum, suggesting that the ACP domain does not adopt multiple
conformations in slow exchange on the chemical shift time scale
(>0.2 s). Nearly complete backbone assignments for apo ACP6
were obtained from a series of standard triple-resonance NMR
experiments. A study of 15N relaxation parameters (Fig-
ure S1B–S1D) indicated that the protein backbone was highly
structured between residues Met2810 and Gln2886. 15N T1
and T2 measurements were used to determine an overall
rotational correlation time of 6.0 ± 0.3 ns, consistent with
a compact 80 amino acid domain and confirming that theChemistry & Biology 17,protein was not prone to self-association (for further details,
see the Supplemental Experimental Procedures).
To guide our solution NMR studies, we used the CHESHIRE
chemical shift-guided de novo structure prediction protocol
(Cavalli et al., 2007) to generate an ensemble of structures for
ACP6. First, we validated this approach by predicting a structure
for DEBS ACP2 from published chemical shifts, which proved
highly similar to the NOE-derived structure (2JU1) previously re-
ported (Alekseyev et al., 2007), yielding a root mean square devi-
ation (RMSD) of 1.7 A˚ between the backbone atom coordinates
of residues 19 to 91 (Figures 2A and 2B). Next, we obtained
a shift-based structure for ACP6 (Figure 2C), which over the
equivalent residue range (Gln2812 to Gly2884) gave RMSD
values of 2.3 A˚ and 2.4 A˚ from the CHESHIRE- and NOE-derived
structures of ACP2, respectively. For comparison, a homology
model of ACP6 returned by the I-TASSER server (Zhang, 2009)
(Figure S1E) possessed essentially the same fold and showed
an RMSD of 2.2 A˚ from the backbone coordinates of our shift-
based structure for ACP6.
In common with DEBS ACP2 (Alekseyev et al., 2007) and
carrier proteins from other FAS, NRPS, and PKS systems
(Kim et al., 2006; Zornetzer et al., 2006; Xu et al., 2001; Roujeini-
kova et al., 2002; Wong et al., 2002; Li et al., 2003; Findlow et al.,
2003; Evans et al., 2008; Frueh et al., 2008), the structure of ACP6
comprises a right-handed twisted bundle formed by three main
a helices (a1, Gln2818–Leu2832; a2, Ser2853–Thr2867; and
a3, Val2882–Gly2890), with a1 running antiparallel to a2 and
a3. In addition, the linker between a1 and a2 contains a few resi-
dues of 310 helix (a2
0, Phe2846–Glu2848), while a short a-helix is
found between a2 and a3 (a30, Leu2875–Glu2878). The globular
fold of ACP6 is maintained by interactions between hydrophobic
side chains, many of which are conserved in ACP2 (including
Leu2820, Val2840, Leu2849, Ala2856, Leu2859, Leu2863,
Thr2867, Leu2871, Leu2875, Leu2885, Ala2886, and Ile2889)
(Figure 1B).705–716, July 30, 2010 ª2010 Elsevier Ltd All rights reserved 707
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Figure 3. Average 1H/15N Chemical Shift Differences Plotted as
a Function of Residue Number
(A) apo ACP6 and holo ACP6.
(B) holo ACP6 and butyryl-ACP6.
(C) holo ACP6 and oxa(dethia) (2RS)-methylmalonyl-ACP6.
(D) holo ACP6 and oxa(dethia) (2RS)-2-methyl-3-ketopentanoyl-ACP6.
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Crump and co-workers recently published the first high-resolu-
tion structures of the apo and holo forms of the same ACP
from the type II actinorhodin PKS (act ACP) (Figure 1B) (Evans
et al., 2008). Overall, the structures are highly similar: compar-
ison of the [1H,15N]-HSQC spectra of both forms yielded
weighted average chemical shift differences (Ddav) of %0.03
ppm for 90% of the backbone amide resonances. Nonetheless,
a detailed analysis revealed that the holo protein is subtly con-
tracted relative to the apo form, a structural switch induced by
interaction between Leu43 on helix a2 (corresponding to ACP6
Leu2854) and the newly added cofactor. This rearrangement is
likely to be responsible for the significant chemical-shift changes
observed for nine residues lying along the first half of helix a2,708 Chemistry & Biology 17, 705–716, July 30, 2010 ª2010 Elsevier Land on helix a30 (average difference 0.21 ppm, maximum differ-
ence 0.5 ppm). On the other hand, chemical shift perturbations to
residues Asp41 and Ser42 (corresponding to ACP6 Asp2852 and
Ser2853, respectively) were attributed to the presence of the
Ppant tethered to Ser42.
We used this information to interpret the effects of modifying
DEBS ACP6 with Ppant. All residue assignments from the
[1H,15N]-HSQC spectrum of apo ACP6 could be transferred to
the ACP6 holo protein. Among these, 93% of the chemical shifts
matched those in the apo domain with weighted average differ-
ences of%0.04 ppm, which we set as the threshold for detecting
minor perturbations (Ddav values are plotted against residue
number in Figure 3A and were calculated as in Evans et al.,
[2008]). These data show that the overall structure of ACP6
does not change substantially following addition of Ppant.
Furthermore, the presence of a single set of 1H-15N correlation
peaks in the spectrum of the holo protein suggests that, like the
apo form, it adopts a single conformation (Figure S2A). Of the 11
amino acid residues in ACP6 that correspond to significantly
affected sites in act holo ACP, only two show chemical shift
changes of comparable magnitude (Asp2852, Ddav 0.11 ppm;
Leu2854, Ddav 0.23 ppm). By analogy to the act ACP, we attri-
bute the effects at Asp2852 and Leu2854 to covalent attachment
of the Ppant arm. The substantial change at Thr2874 (0.25 ppm)
and the more minor perturbation to Val2876 (0.05 ppm) are likely
to arise from transient interaction with the Ppant group, to which
they sit in proximity on the surface of the protein (Figure S2B).
Similar prosthetic group dynamics have been reported for type
II ACPs (Kim et al., 2006; Li et al., 2003; Wong et al., 2002;
Xu et al., 2001; Zornetzer et al., 2006). Taken together, these
results suggest that the overall effects of phosphopantetheinyla-
tion on the structure are minor.
Next, we evaluated whether ACP6 might change conformation
upon interaction with acyl groups attached to its Ppant arm, as
such conformational remodeling has been described for ACPs
of both type II PKS (Evans et al., 2009) and FAS (Roujeinikova
et al., 2002; Roujeinikova et al., 2007; Wu et al., 2009;
Mayo and Prestegard, 1985; Zornetzer et al., 2006). We initially
investigated the established substrate mimic butyrate 1 (Tran
et al., 2008), an unfunctionalized chain which is bound by both
type II PKS (Evans et al., 2009) and FAS (Roujeinikova et al.,
2002; Roujeinikova et al., 2007; Wu et al., 2009) ACPs. Butyrate
was transferred to the apo ACP6 from its CoA thioester using the
broad-specificity phosphopantetheinyl transferase Sfp (Quadri
et al., 1998). Detailed comparison of the [1H,15N]-HSQC spec-
trum of butyryl-ACP6 with that of the holo protein provided no
evidence for significant interactions between the domain and
the attached substrate (Figure 3B); the majority of Ddav values
were%0.035 ppm, and only two surface residues in the vicinity
of Ser2853 showed larger chemical shift changes (0.076 and
0.082 ppm for Asp2852 and Thr2874, respectively). Ddav values
of this magnitude were observed in a study comparing holo and
acyl forms of the actinorhodin type II ACP, in which full structure
elucidation of the acyl-ACP species confirmed the absence of
interaction between the protein and the bound substrates (Evans
et al., 2009). To bolster this result, we compared the 1H and 13C
NMR spectra of butyryl-pantetheine 2, 13C4-labeled butyryl-CoA
3, and 13C4-butyryl-
12C-ACP6. The
13C4-labeled butyryl-CoA 3
was prepared from its pantetheine derivative 4 in a one-pottd All rights reserved
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Figure 4. Synthesis of 13C-Butyryl-CoA and Oxa(dethia)-CoA Derivatives in a One-Pot Reaction
The CoA analogs are generated from the corresponding pantetheine derivatives using pantothenate kinase (PanK), phosphopantetheine adenyltransferase
(PPAT), and dephosphocoenzyme A kinase (DPCK). X corresponds to 13C-labeled butyrate, oxa(dethia)-(2RS)-methylmalonate, and oxa(dethia)-(2RS)-2-
methyl-3-ketopentanoate.
Table 1. Chemical Shift Changes Observed in the Series Butyryl-
pantetheine, 13C4-Labeled Butyryl-CoA,
13C4-Butyryl-
12C-ACP6,
13C4-Butyryl-
12C-ACP6 + TE (titration), and
13C4-Butyryl-
12C-
ACP6-TE (Relative to Butyryl-CoA)
C4 (CH3 site) d(H)/ppm d(C)/ppm Dd(H)/ppm Dd(C)/ppm
Butyryl-pantetheine 0.927 15.43 0.043 0.06
Butyryl-CoA 0.884 15.49 0 0
Butyryl-ACP6 0.849 15.66 0.035 0.17
Butyryl-ACP6/TE
(titration)
0.854 15.66 0.03 0.17
Butyryl-ACP6-TE 0.849 15.66 0.035 0.17
C3 (CH2 site)
Butyryl-pantetheine 1.663 21.82 0.055 0.13
Butyryl-CoA 1.608 21.69 0 0
Butyryl-ACP6 1.58 21.73 0.028 0.04
Butyryl-ACP6/TE
(titration)
1.58 21.73 0.028 0.04
Butyryl-ACP6-TE 1.58 21.82 0.028 0.13
C2 (CH2 site)
Butyryl-pantetheine 2.635 48.22 0.067 0.09
Butyryl-CoA 2.568 48.13 0 0
Butyryl-ACP6 2.528 48.22 0.04 0.09
Butyryl-ACP6/TE
(titration)
2.528 48.22 0.04 0.09
Butyryl-ACP6-TE 2.528 48.22 0.04 0.09
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phopantetheine adenyltransferase (PPAT) and dephosphocoen-
zyme A kinase (DPCK) (Nazi et al., 2004) (Figure 4). (This
synthesis and that of 12C- (2) and 13C4-butyryl-pantetheine 4
are described in the Supplemental Experimental Procedures.)
Although minor chemical shift changes were observed between
the three butyrate species (Table 1), these minimal perturbations
confirm the absence of significant, persistent interactions
between the acyl chain and the ACP domain. These results
strengthen the view that unlike type II FAS and PKS ACP
domains, type I ACPs show no significant affinity for hydro-
phobic chain assembly intermediates (Wattana-Amorn et al.,
2010; Ploskon et al., 2008).
As butyrate lacks the complex functionality of the natural hep-
taketide intermediate attached to ACP6, we also investigated
chemical shift effects caused by two more native substrate
analogs. For this we chose a diketide mimic ([2RS]-2-methyl-3-
ketopentanoate), as well as a racemic analog of the natural chain
extension unit (2S)-methylmalonate (Marsden et al., 1994)
(Figure 4). Both compounds were synthesized in hydrolytically
stable form, taking advantage of recently developed method-
ology for the preparation of oxa(dethia)pantetheine (Tosin
et al., 2010) and coenzyme A analogs (Tosin et al., 2009). In brief,
(2RS)-2-methyl-3-ketopentanoate and (2RS)-methylmalonate
were synthesized as their oxa(dethia) pantetheine esters (5 and
6, respectively) (Supplemental Experimental Procedures) and
then converted to the corresponding CoA compounds (7 and
8) using PanK, PPAT, and DPCK (Nazi et al., 2004). Transfer of
these acyl-phosphopantetheines to ACP6 was achieved using
Sfp. Again, [1H,15N]-HSQC experiments revealed no significant
interactions between the acyl groups and the protein (Figures
3C and 3D). It has been recently reported that ACP6 can collab-
orate in vitro with a didomain consisting of a ketosynthase (KS)Chemistry & Biology 17,and an acyltransferase (AT) to synthesize 2-methyl-3-ketodike-
tide-ACP6 (Valenzano et al., 2009). By reductive trapping with
NaBH4, the methyl group was found to be configurationally705–716, July 30, 2010 ª2010 Elsevier Ltd All rights reserved 709
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Figure 5. Analysis for Binding between Butyryl-ACP6 and TE in trans
(A) Average 1H/15N chemical shift differences for butyryl-ACP6 in the presence
and absence of TE (S3030A).
(B) Average 1H/15N chemical shift differences for ACP6 (S2853A) in the pres-
ence and absence of Sfp.
(C) [1H, 15N]-HSQC resonance height ratios for ACP6 (S2853A) in the presence
and absence of Sfp.
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with ACP6. However, this hypothesis is inconsistent with the lack
of such contacts in our experiments. We suggest instead that
stabilization may arise through an interface with the KS-AT dido-
main, but, nevertheless, the exact basis for this discrepancy
remains to be determined.
Interaction between DEBS Acyl-ACP6 and TE in trans
We previously used in vitro enzymatic assays to show that
a discrete TE can catalyze release of butyrate 1 from isolated
ACP6, albeit inefficiently (pseudo first order rate constant
k = 0.00101 ± 0.00002 s1) (see Supplemental Experimental
Procedures). Furthermore, comparative analysis of the interac-
tion between the TE and various forms of ACP6 (apo, holo, and
butyryl) by isothermal titration calorimetry (ITC) and surface plas-
mon resonance (SPR) suggested that the binding by the TE was
limited to the Ppant arm and/or the acyl chain. We aimed to
confirm these results using NMR, monitoring butyryl-15N-ACP6
(500 mM) in the presence of the TE (200 mM), suppressing cata-710 Chemistry & Biology 17, 705–716, July 30, 2010 ª2010 Elsevier Llytic turnover by employing an active site mutant of the TE
(Ser3030Ala). This experiment was carried out under conditions
identical to the previous enzymatic assays (Tran et al., 2008),
with the exception that the spectra were acquired at 25C
instead of 37C; crucially, we confirmed that the wild-type TE still
catalyzed turnover of butyryl-ACP6 at this lower temperature
(k = 0.00076 ± 0.00003 s1).
We looked for evidence of binding to TE (S3030A) in the
[1H,15N]-HSQC spectrum of the ACP6 domain, including signif-
icant changes from the chemical shifts of butyryl-ACP6 alone
which would identify interface residues, and line broadening
effects that might indicate formation of an ACP/TE protein-
protein complex. We observed neither (Figure 5A), even though
the final concentrations of both domains were far in excess of
the KD for binding measured by ITC (18 ± 1 mM) (Tran et al.,
2008). These negative results support the idea that the TE
can interact with ACP-tethered substrates in the absence of
contact with the ACP domain itself. We also carried out analo-
gous titrations with nonhydrolyzable (2RS)-2-methyl-3-keto-
pentanoate (derived from 7, Figure 4) bound to ACP6 (molar
ratios ACP6:TE 4:1, 2:1 and 1:1). Again, we found no evidence
for persistent interactions between the TE and the ACP6
domain (Figure S3A).
To demonstrate that we could detect formation of a protein-
protein complex using our NMR methodology, we analyzed the
interaction between apo ACP6 and the PPTase Sfp. We had
shown previously by site-directed mutagenesis of ACP6 coupled
with assays in vitro, that Sfp interacts directly with ACP6, con-
tacting several residues along the length of helix a2 (Weissman
et al., 2006). However, we were unable to analyze the interaction
with wild-type apo ACP even in the absence of added Mg2+ and
CoA cofactors, as conversion to the holo form in the presence of
Sfp was rapid. To prevent this reaction, we replaced the active
site Ser2853 of ACP6 with Ala (Koglin et al., 2006); [
1H,15N]-
HSQC experiments showed that the mutation is isomorphous,
leaving the domain essentially unchanged except in the imme-
diate vicinity of residue 2853 (Figure S3B). From preliminary
experiments, we determined that it was necessary to premix
Sfp with equimolar quantities of CoA and Mg2+; addition of
Sfp in the absence of either CoA orMg2+ resulted in poor stability
of the PPTase, as well as nonspecific binding to ACP6 (S2853A).
We then acquired [1H,15N]-HSQC spectra of ACP6 (S2853A) as
Sfpwas titrated into the solution (ACP6 [S2853A]:Sfpmolar ratios
of 1:0, 4:1, 2:1, and 1:1). For technical reasons we assigned only
87% of the expected signals for ACP6 (S2853A), but a compar-
ison of spectra acquired in the absence and presence of Sfp al-
lowed us to identify a set of amino acids at the intermolecular
interface (Ddav [ppm] values are plotted against residue number
in Figure 5B). Consistent with our mutagenesis results (Weiss-
man et al., 2006), interface residues were identified on helix a2,
but additionally on helix a30, a3, and the intervening loops; little
interaction was observed with the N-terminal half of the protein.
In addition, analysis of peak intensities showed that all ACP6
(S2853A) resonances were broadened in the presence of Sfp,
as expected when a small protein participates in a complex
(MW Sfp = 22 kDa) (Figure 5C). This analysis acts as a positive
control for our TE binding experiments, demonstrating that our
data accurately reflect the absence of direct contact between
the TE and ACP6 domains.td All rights reserved
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Figure 6. Interactions of DEBS Acyl-ACP6 and TE in cis
Expanded view of the [1H, 15N]-HSQC spectra of (A) apo ACP6-TE and apo ACP6 + TE, (B) holo ACP6-TE and holo ACP6 + TE, (C) butyryl-ACP6-TE and butyryl-
ACP6 + TE, and (D) oxa(dethia)-(2RS)-2-methyl-3-ketopentanoyl-ACP6-TE (diketide-ACP6-TE) and diketide-ACP6 + TE. Average
1H/15N chemical shift differ-
ences plotted as a function of residue number for (E) apo ACP6-TE and apo ACP6 + TE, (F) holo ACP6-TE and holo ACP6 + TE, (G) butyryl-ACP6-TE and
butyryl-ACP6 + TE, (H) diketide-ACP6-TE and diketide-ACP6 + TE.
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Transfer of butyrate 1 between ACP6 and TE is extremely rapid
when the domains are covalently linked (Tran et al., 2008).
Thus, it remained a formal possibility that the domains assemble
into a complex at the high effective concentrations produced by
direct tethering within the DEBS multienzyme by a short
(11 residue) linker. To evaluate this question directly, we
compared the [1H,15N]-HSQC spectra of apo 15N-ACP6, His6-
tagged apo 15N-ACP6-TE and His6-tagged
15N-TE. Due to over-
lap with the TE signals, we were only able to reassign 42 of 76
ACP resonances in the spectrum of the ACP6-TE didomain,
but their frequencies were essentially unchanged relative to the
discrete protein (Figures 6A and 6E). The major exceptions
were for residues at or near the direct covalent linkage between
the two domains. We also observed a small extent of line broad-
ening for the ACP signals. The magnitude of this change is not
consistent with formation of a tight complex between the
proteins but instead indicates that tethering to another domainChemistry & Biology 17,moderately restricts the mobility of the ACP. Similarly, ACP resi-
dues in the holo ACP6-TE (34 signals) overlaid well with those
from the discrete holo ACP6 (Figures 6B and 6F), in that both
were shifted to the same minor extent from their apo forms.
We next extended this analysis to two acyl-ACP6 species,
butyryl-ACP6-TE (S3030A) and oxa(dethia)-(2RS)-2-methyl-3-
ketopentanoyl-ACP6-TE (S3030A). In both cases, the detect-
able signals from the ACP domain (31 and 33, respectively)
overlaid well with those of equivalently modified discrete ACP
domains (Figures 6C, 6D, 6G, and 6H; Figure S4). We had antic-
ipated that the ACP domain might experience additional
motional restraints when the attached substrate bound into
the TE active site, leading to a broadening of resonances rela-
tive to those in spectra of the tethered holo domain. Intriguingly,
however, the signals from both acyl-ACP-TE species had
similar linewidths to those from the apo and holo ACP-TE
constructs. This observation suggested that only the extreme
Ppant-attached end of the substrate becomes restricted on705–716, July 30, 2010 ª2010 Elsevier Ltd All rights reserved 711
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relatively mobile.
To obtain direct evidence for this mode of binding, we gener-
ated uniformly labeled 13C4-butyryl-
12C-ACP6-TE (S3030A) and
compared its behavior to 13C4-butyryl-
12C-ACP6 using
a [1H, 13C]-HSQC experiment, which detects carbon nuclei
which are directly attached to hydrogen atoms. The chemical
shifts for C2, C3, and C4 of butyrate matched closely in both
samples, indicating the absence of an interaction with the TE
in the didomain (Table 1; Figure S5). To directly interrogate the
remaining carbonyl carbon (C1), we carried out a modified
H(CA)CO experiment (Supplemental Experimental Procedures),
which revealed a 13C chemical shift change of 0.33 ppm, consis-
tent with binding to the TE (compare Figures 7A and 7B). To
further confirm this result, we analyzed 13C4-butyryl-
12C-ACP6
(initial concentration of 1.25 mM in the presence of increasing
concentrations of TES3030A (final ACP6:TE molar ratios of 1:0,
1:0.25, 1:0.5, and 1:1). In agreement with the result for the dido-
main, there were no significant chemical shift changes for
aliphatic sites at any TE concentration (Table 1). Unexpectedly,
we also failed to detect a change in shift for the carbonyl 13C
resonance, even at 1:1 ACP6:TE (final concentration of both
species 0.5 mM). However, upon increasing the concentration
of the 1:1 mixture to 3.1 mM in each species, we detected
a carbonyl 13C shift of 0.18 ppm in the same direction as that
found for the acyl-didomain (Figure S5). Crucially, the magnitude
of the shift changes in both the didomain and titration experi-
ments substantially exceeded the sample-to-sample variation
observed in spectra of discrete 13C4-butyryl-ACP6 preparations.
(For additional discussion of this experiment and its interpreta-
tion, see the Supplemental Experimental Procedures.) Taken
together, these data show that within the context of the multien-
zyme the interaction between butyryl-ACP6 and the TE complex
is minimal and is likely to be limited to the C1 carbonyl group of
the acyl chain (although interactions with the Ppant arm cannot
at present be ruled out). This finding implies that the TE domain
should exhibit broad substrate tolerance in the acylation reac-712 Chemistry & Biology 17, 705–716, July 30, 2010 ª2010 Elsevier Ltion, an expectation confirmed by analysis in vitro of ACP6-TE
with a range of substrate analogs varying in both chain length
and functionality (Aggarwal et al., 1995).
Although somewhat unexpected, these results are also
entirely consistent with two recent studies on substrate binding
by isolated DEBS TE (Wang and Boddy, 2008) and the homolo-
gous TE from the pikromycin (Pik) PKS (Akey et al., 2006;
Giraldes et al., 2006). The data obtained respectively from site-
directed mutagenesis and polyketide-based affinity labeling
show a lack of direct, specific contact between the TE domains
and the acyl chains, both in the substrate loading step (as shown
for DEBS TE), and prior to the cyclization reaction (Pik TE). No
evidence has been adduced for substrate recognition via
specific hydrogen bonds or by a protein surface of complemen-
tary shape, using a range of substrate analogs including a near-
native pentaketide mimic of pikromycin (Akey et al., 2006;
Giraldes et al., 2006). These findings are highly relevant to the
data reported here, as it could have been argued that extensive
interaction between the TE and the incoming substrate might
provoke a conformational change in the TE domain, exposing
a new interface to the upstream ACP. On the contrary, the struc-
tures of unbound and substrate-modified Pik TE were found to
be identical (Giraldes et al., 2006). To explain the ability of the
TEs to catalyze macrolactonization using both ends of the sub-
trate, Akey and co-workers identified a ‘‘hydrophilic barrier’’ at
the exit site of the Pik TE substrate channel (Akey et al., 2006).
This region forces the substrate to curl back upon itself, causing
its distal end to approach the active site Ser. Chain release via
a classical tetrahedral intermediate is then facilitated by an oxy-
anion hole, provided in the case of the PikTE by the NH group of
Gly149. We note that this interaction with the C1 carbonyl group,
one of only two direct contacts demonstrated to date between
the PikTE and a substrate mimic, is precisely that observed
between DEBS TE and butyrate.
DISCUSSION
Biosynthesis of polyketide and nonribosomal peptides requires
the coordinated action of minimally tens of individual catalytic
domains, housed within large multienzyme subunits. The reac-
tions occur on substrates attached in thioester linkage to the
Ppant prosthetic group of integral carrier proteins. Conse-
quently, these small, noncatalytic domains have taken center
stage in efforts to elucidate assembly-line production of natural
products (Lai et al., 2006; Weissman and Mu¨ller, 2008). X-ray
crystallographic studies of both PKS (Tang et al., 2006) and
NRPS (Samel et al., 2007; Tanovic et al., 2008) have shown
that the distance between successive catalytic domains
exceeds the reach of a static Ppant arm, implying that the entire
carrier proteins must relocate within the complexes to deliver
their cargo. NMR has been arguably even more informative,
revealing that in the case of the tyrocidine NRPS, this dynamic
theme extends to the structure of the PCP domain itself (Koglin
et al., 2006). Conformational rearrangements through interaction
with Ppant and by extension with substrate appear to optimize
PCPs for complex formation with specific partners, in principle
dictating the sequence of interactions during each chain exten-
sion cycle. The catalytic domains may contribute an additional
layer of regulation, as an NRPS TE has been shown to fliptd All rights reserved
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and concealing its Ppant binding site (Frueh et al., 2008).
Similar control features have also been proposed to operate in
PKS systems (Frueh et al., 2008; Weissman and Mu¨ller, 2008;
Kapur and Khosla, 2008; Lai et al., 2006), and this remains an
appealing mechanism. However, the data reported here strongly
support the idea (Tran et al., 2008) that at least some ACP-based
communication is facilitated solely by the proximity of the ACP
and its partner domains within the multienzyme complex. In
the case of the interaction between acyl-ACP and the TE
domain, chain transfer can occur efficiently in the absence of
a protein-protein interface, with contact limited to the substrate.
These results are entirely consistent with the finding that the
DEBS TE can partner effectively with multiple, noncognate ACP
domains in engineered PKS systems in vivo (Corte´s et al., 1995;
Martin et al., 2003). In addition, our data provide no evidence for
conformational heterogeneity within a typical ACP domain,
whether induced through contacts with Ppant or acyl substrates.
However, as our studies were carried out with the chain exten-
sion unit methylmalonate and short chain polyketide mimics,
we cannot yet rule out that PKS ACPs interact with longer,
more highly functionalized intermediates. Nonetheless, our
results clearly demonstrate that conformational switching is
not absolutely required for effective communication with the
TE domain.
This means of cooperation may also apply to ketoreductase
domains, which exhibit a relaxed specificity toward their ACP
partners (Chen et al., 2007). In contrast, both KS and AT domains
show a preference for particular ACPs (Wong et al., 2010; Kim
et al., 2004; Chen et al., 2006), a specificity that in the case of
the KSs can be influenced by site-directed mutagenesis at
ACP surface residues (Alekseyev et al., 2007). These results
are consistent with formation of a specific protein-protein inter-
face between the ACP domain and the KS and AT enzymes,
which together constitute the core of a functional PKS module.
Thus, several modes of ACP-centered communication appear
to operate simultaneously in type I PKS systems. This finding
accords with a proposed mechanism for the evolution of
modular PKSs (Jenke-Kodama et al., 2006), in which catalytic
domains, with the exception of KSs, are added, deleted, or
exchanged into a given module by homologous recombination
within the interdomain linker regions. From this perspective,
a model in which at least some of the resulting ACP partnerships
are facilitated by proximity instead of optimized protein-protein
interfaces is attractive.
As the interaction between the ACP and TE domains is prox-
imity driven, how then is chain transfer controlled so that the
appropriate level of processing is achieved within the chain
extension module before the substrate is handed on to the TE
domain? Several possible mechanisms can be envisaged. For
example, the TE may regulate access to its active site via
a mobile flap, as demonstrated for TEs from the enterobactin
(Frueh et al., 2008) and surfactin (Bruner et al., 2002) NRPSs.
However, the X-ray structures of the TEs from the DEBS (Tsai
et al., 2001) and Pik (Tsai et al., 2002) PKSs provide no direct
evidence that these domains can adopt the requisite open and
closed conformations, although studies of dynamics in solution
may yet reveal greater conformational flexibility. Alternatively,
chain transfer to the TE may not be tightly regulated, but off-Chemistry & Biology 17,loading may occur relatively slowly. According to this ‘‘retarda-
tion control’’ mechanism, the subsequent chain extension inter-
mediate would stall within the upstream module, providing
adequate time for all reductive reactions to occur (Hong et al.,
2009). A final possibility is suggested by a recent electron
microscopy study of type I animal FAS, a multienzyme which is
likely to share architectural features with modular PKS (Smith
and Tsai, 2007; Weissman, 2008). FAS carries out an analogous
set of reactions to a fully reducing PKS module, using sets of
domains organized into two independent reaction chambers.
The domains are deployed iteratively until the appropriate chain
length is reached, and then the mature fatty acid is liberated by
the terminal TE domain. Catalysis of substrate loading and chain
extension require asynchronous closing of the two reaction
chambers, a global conformational rearrangement which simul-
taneously appears to block access of the TE to the ACP (Brignole
et al., 2009). Whether this exclusion mechanism also operates in
modular PKS to control the timing of chain release will only be re-
vealed by high-resolution data on an intact module, combined
with dynamical information.
An important motivation for studying PKS systems is to
improve our ability to genetically manipulate thesemultienzymes
toward the production of novel metabolites, an approach
referred to as combinatorial biosynthesis (Weissman and Lea-
dlay, 2005). One of the most successful strategies has been to
exchange specific catalytic domains within and between
different synthases. While several hundred new compounds
have been generated to date by this method, hybrid assembly
lines are often kinetically compromised relative to their parents,
produce undesirable mixtures of products because specific
domains fail to act, or are simply nonfunctional. Although there
are likely to be several explanations for these results, our data
support the idea that the failure to maintain proper spatial rela-
tionships between the ACP and its partners may alone account
for a number of these findings (Hans et al., 2003). This is encour-
aging, because it implies that structural data on representative
modules which reveal the relative dispositions of the ACP and
catalytic domains will substantially advance efforts to make
such engineering routine.
SIGNIFICANCE
Biosynthesis of complex polyketide metabolites requires
the coordinated action ofminimally tens of individual protein
domains housed within gigantic multienzyme assembly
lines (modular polyketide synthases [PKSs]). The central
players in the pathways are small, noncatalytic acyl carrier
protein (ACP) domains, to which the growing polyketide
chains are tethered in covalent linkage. Little is known about
how the catalytic domains communicate with acyl-ACPs or
how these interactions are controlled, which are features
that must be preserved if efforts to generate novel polyke-
tide analogs by genetic engineering (so-called ‘‘combinato-
rial biosynthesis’’) are to be successful. Based on similarities
in biosynthetic logic between PKSs and the nonribosomal
peptide synthetases (NPRSs), it has been suggested that
the choice of catalytic partner in modular PKS is guided by
substrate-induced conformational switching in the ACP
domain. That is, contacts with the substrate modulate the705–716, July 30, 2010 ª2010 Elsevier Ltd All rights reserved 713
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with a specific partner. We have addressed this hypothesis
directly by using amodel system comprising an ACP domain
and its adjacent thioesterase (TE), from the PKS responsible
for erythromycin biosynthesis. Using a combination of NMR,
site-directed mutagenesis, chemical synthesis, and site-
specific protein labeling, we demonstrate that the ACP
adopts a single conformation in solution and does not
interact substantially with either attached phosphopante-
theine cofactor or substrate. In addition, effective chain
transfer between the ACP and the TE occurs in the absence
of a defined protein-protein complex, and instead recogni-
tion focuses on the carbonyl group of the acyl chain. Taken
together, these findings argue against the proposed
programming model, revealing a fundamental mechanistic
difference between modular PKS and NRPS systems.
EXPERIMENTAL PROCEDURES
Biological Materials and General Methods
All chemicals were reagent grade. Ampicillin, kanamycin, chloramphenicol,
Bradford reagent, glutathione, Tris (tris hydroxymethylaminomethane), and
EDTA (ethylenediamine tetraacetic acid) were purchased from Sigma. IPTG
(isopropyl-b-D-thiogalactopyranoside) and dithiothreitol (DTT) were obtained
from Melford Laboratories, Ltd. NaH2PO4 and NaCl were purchased from
Fischer Chemicals. Complete protease inhibitor cocktail tablets were obtained
from Roche Molecular Biochemicals. 15N-labeled Celtone, 13C-labeled
glucose, and 15N-labeled ammonium chloride were obtained from Spectra
Stable Isotopes. Strain Escherichia coli BL21-CodonPlus-RP was obtained
from Stratagene. Standard procedures for DNA isolation and manipulation
were performed as described previously (Sambrook and Russell, 2001).
Restriction endonucleases and T4 DNA ligase were obtained from New
England Biolabs. Mutagenic PCR was carried out using the QuickChange
Site-Directed Mutagenesis Kit (Stratagene), while standard PCR reactions
were performed with Pfu polymerase (Stratagene). Synthetic oligonucleotides
were purchased from Invitrogen, and automated DNA sequencing was carried
out on double-stranded DNA templates using an automated ABI Prism 3700
DNA Analyzer (Applied Biosystems).
Chemical Materials and General Methods
NMR spectra were recorded at 300 K using Bruker DPX-400, Avance 400 QNP
and Avance 500 spectrometers. For 1H- and 13C-NMR the chemical shifts are
reported relative to the solvent signal (CDCl3 dH 7.26, D2O dH 4.80, CD3OD dH
3.31, CDCl3 dC 77.0, and CD3OD dC 49.0). The
1H- and 13C-NMR signals were
unequivocally assigned with the aid of g-COSY, DEPT and HMQC. All chem-
icals were purchased from Sigma-Aldrich (unless otherwise stated). The reac-
tion solvents were dried and distilled according to the methods of Burfield and
Smithers (1983). HPLC purification was carried out on a semi-preparative
Phenomenex Synergi polar RP column (2503 10.0 mm, 4 mm) using an Agilent
HP 1100 HPLC; mixtures of water and acetonitrile (with addition of FA when
stated) were used with a flow rate of 2.5ml min1 with an elution gradient start-
ing from 100% water and linearly increasing to 100% acetonitrile over 30 min
(unless otherwise stated), with UV detection set at 254, 280, and 210 nm. LR-
and HR-ESI-MS spectra of synthetic intermediates were obtained from an
Agilent HP1100 HPLC coupled to a Finnigan MAT LCQ mass spectrometer
(fitted with an ESI source) and a Waters LCT Premier mass spectrometer
respectively. HR-ESI-MS analysis of final purified products was performed
on a Thermo Electron LTQ-Orbitrap (run in positive ionization mode, scanning
from m/z 100 to 1800, with the FTMS analyzer resolution set at 60K).
Design of Expression Constucts
DEBS ACP6 was amplified as a BamHI-EcoRI fragment from plasmid
pKJW191R (Weissman et al., 2004) using primers ACP6NBam and ACP6CEco
(all primer sequences are provided in the Supplemental Experimental Proce-
dures). DEBS TE was amplified as a BamHI-EcoRI fragment from plasmid714 Chemistry & Biology 17, 705–716, July 30, 2010 ª2010 Elsevier LpKJW191R using primers TENBam and TECEco. The PCR products were di-
gested with BamHI and EcoRI and ligated into pGEX-6P-1, yielding plasmids
pGEX-ACP6 and pGEX-TE, repsectively. The construction of plasmids
pKJW63 (C-terminally His6-tagged TE), pACP-TEHis, and pSfp was described
previously (Tran et al., 2008). Single serine to alanine active sitemutationswere
introduced into ACP6 byQuickchange site-directedmutagenesis (Stratagene),
using the primers ACPsS2853A and ACPaS2853A to generate pGEX-AC-
P6(S2853A), and into the TE and the ACP6-TE didomain using primers
TEsS3030A and TEaS3030A, yielding pGEX-TE(S3030A) and pACP6-TE
(S3030A). The fidelity of all PCR and mutagenesis reactions was confirmed
by sequencing. The sequences of proteins created in this study are provided
in the Supplemental Experimental Procedures. Cloning of PanK, PPAT, and
DPCK (Nazi et al., 2004) is described in detail in Tosin et al., (2009).
Expression of Labeled and Unlabeled Protein Samples for NMR
analysis
GST-tagged TE (S3030A) and N-terminally His6-tagged Sfp were expressed in
Escherichia coli BL21 (DE3) CodonPlusRP (Stratagene) for 5 hr in LB medium
supplementedwith 50mgml1 chloramphenicol and 100mgml1 carbenicillin
(TE [S3030A]) or 50 mgml1 kanamycin (His6-tagged Sfp) at 30C, after induc-
tion with 0.2 mM IPTG. TE (S3030A) was subsequently released from GST by
limited proteolysis with PreScission Protease as described in the Supple-
mental Experimental Procedures. To obtain uniformly labeled 15N-labeled
ACP6, ACP6 (S2853A), ACP6-TEHis (S3030A), and TEHis, cells were grown for
16 hr at 22C in M9 minimal medium containing 15N-labeled ammonium chlo-
ride (Spectra Stable Isotopes) (and 1% 15N-labeled Celtone for ACP6
[S2853A]), in the presence of the appropriate antibiotics, after induction with
0.2 mM IPTG. 13C,15N-labeled ACP6 was obtained using the same medium,
but supplemented additionally with 13C-labeled glucose. All constructs were
purified as described in the Supplemental Experimental Procedures, and the
protein identities confirmed by HPLC-MS (Figures S6A, S6F, and S6H).
Enzymatic Synthesis of CoA Analogues
Nonhydrolyzable diketide pantetheine, nonhydrolyzable methylmalonyl pante-
theine, and 13C-butyryl-pantetheine were synthesized as described in the
Supplemental Experimental Procedures. Five millimolar pantetheine deriva-
tive was dissolved in reaction buffer (20 mM KCl, 10 mM MgCl2, 20 mM
ATP, and 50 mM Tris.Cl [pH 7.5]), and the reaction was initiated by addition
of 5 mg PanK, 5 mg PPAT, and 5 mg DPCK (Nazi et al., 2004; Tosin et al.,
2009). Reaction mixtures were incubated at 22C for 3 hr, and the reactions
were monitored for completion by HPLC-MS analysis (Figures S6M, S6N,
and S6O) using a Polar RP 80 A˚ column (2503 2.00 mm) with a linear gradient
(25%–95% acetonitrile/water containing 0.1% trifluoroacetic acid), over 20
min at a flow rate of 0.3 ml min1. Further information on analysis by HPLC-
MS is provided in the Supplemental Experimental Procedures.
Phosphopantetheinylation andAcylation of ACP6 andACP6-TES3030A
Onemillimolar ACP6 or ACP6-TEHis (S3030A) was incubated with 31 nM Sfp, in
buffer (50 mM NaPi [pH 7.0], 10 mM MgCl2, 5 mM DTT, and 2 mM CoASH [or
acyl-CoASH]) in a 2 ml reaction volume. Reactions were allowed to proceed at
22C for 2 hr, before purification by gel filtration using a Superdex 75 size
exclusion column (Amersham) in PBS (50 mM sodium phosphate buffer [pH
8.0], 150 mM NaCl). To confirm quantitative modification (Figures S6B–E,
S6G, and S6I– S6L), samples were subsequently analyzed by HPLC-MS using
a reverse phase column (Vydac, Protein C4, 5 mm, 250 3 2.0 mm, 300 A˚) with
a linear gradient (25%–95% acetonitrile/water containing 0.1% trifluoroacetic
acid), over 20 min at a flow rate of 0.3 ml min1.
Protein NMR Spectroscopy
Typical samples were prepared containing 1 mM of 15N or 15N/13C-labeled
protein in a solution of 50mM sodium phosphate and 150mM sodium chloride
(pH 8.0), with 20 mM 3,3,3-trimethylsilylpropionate (TSP), protease inhibitor
cocktail (Roche), and 10%D2O, to a final volume of 500 ml in 5 mmUltra-Impe-
rial grade NMR tubes (Wilmad). [1H, 15N]-HSQC, HNCA, HN(CO)CA, HNCO,
HNCACB, CBCA(CO)NH, 15N-NOESY-HSQC, 15N-HSQC-NOESY-HSQC,
and 15N-relaxation and modified H(CA)CO spectra were recorded using stan-
dard procedures (Palmer et al., 2006) at 20C (titration experiments), 25C
(15N relaxation experiments), or 35C on Bruker DRX500, DRX600, andtd All rights reserved
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analysis, see the Supplemental Experimental Procedures.
Modeling of the ACP6 Structure
The CHESHIRE (Cavalli et al., 2007) de novo structure determinations for ACP2
and ACP6 were performed by generating 40,000 low-resolution structures
using a fragment replacement procedure, followed by energy minimization
and chemical shift guided selection of the 250 best matches for further refine-
ment. Six thousand five hundred structures were generated in the refinement
stage, entailing repeated rounds of random selection of structures for simu-
lated annealing and subsequent updating of the list of high-scoring structures.
The 10 best scoring structures were selected as the final ensemble. Over
residues 19–91, the backbone RMSD for the ACP2 ensemble was 0.4 A˚.
Over residues 2812–2884, the RMSD for the ACP6 ensemble was 1.4 A˚; this
comprised a low energy family of seven structures (RMSD 0.5 A˚) and a higher
energy group of three structures (RMSD 0.4 A˚). In each case, the lowest energy
conformation was taken to be representative. A sequence-based homology
model of ACP6 was obtained from the I-TASSER server (Zhang, 2009)
(http://zhang.bioinformatics.ku.edu/I-TASSER/) using the default settings.
Interaction of DEBS acyl-ACP6 and TE in trans
A [1H, 15N]-HSQC spectrum of butyryl-15N-ACP6 (1 mM) was recorded,
TES303A (400 mM) was then added to the solution, and a second [
1H, 15N]-
HSQC spectrum was obtained. Similarly, [1H, 15N]-HSQC spectra were
recorded of 2-methyl, 3-keto-diketide-15N-ACP6 and (2RS)-methylmalo-
nate-15N-ACP6 (1mM), and then TE (1mM)was titrated in stepwise to give final
ACP:TE ratios of 4:1, 2:1, and 1:1. For the positive control with Sfp, the PPTase
was incubated with a 2-fold excess of CoA andMg2+. The Sfp (1 mM) was then
titrated into a 1mMsample of ACP (S2853A), to give final ACP:Sfp ratios of 4:1,
2:1, and 1:1.
ACCESSION NUMBERS
The chemical shift data for apo DEBS ACP6 have been deposited with the Bio-
MagResBank (BMRB) under accession number 16966.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found online at doi:10.1016/j.chembiol.2010.05.
017.
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